References

1. Wallace EL, Surgenor DM, Hao HS, An J, Chapman RH, Churchill WH: Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993; 33:139-44
2. Office of Medical Applications of Research, National Institutes of Health: Fresh-frozen plasma: Indications and risks. JAMA 1985; 253:551-3
3. Office of Medical Applications of Research, National Institutes of Health: Platelet transfusion therapy. JAMA 1987; 257:1777-80
4. Office of Medical Applications of Research, National Institutes of Health: Perioperative red blood cell transfusion. JAMA 1988; 260:2700-3
5. American College of Obstetricians and Gynecologists: Blood component therapy, Technical Bulletin no. 78. Washington, DC: American College of Obstetricians and Gynecologists, 1984
6. Goodnough LT, Johnston MF, Ramsey G, Sayers MH, Eisenstadt RS, Anderson KC, Rutman RC, Silberstein LE: Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 1990; 50:675-83
7. American College of Physicians: Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116:403-6
8. College of American Pathologists: Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 1994; 271:777-81
9. Stehling L, Luban NL, Anderson KC, Sayers MH, Long A, Attar S, Leitman SF, Gould SA, Kruskall MS, Goodnough LT, Hines DM: Guidelines for blood utilization review. Transfusion 1994; 34:438-48
10. Woolf SH: Practice guidelines: A new reality in medicine: II. Methods of developing guidelines. Arch Intern Med 1992; 152:946-52
11. Arens JF: A practice parameters overview. ANESTHESIOLOGY 1993; 78:380-94
12. DePalma L, Luban NL: Blood component therapy in the perinatal period: Guidelines and recommendations. Semin Perinatol 1990; 14:403-15
13. Voak D, Cann R, Finney RD, Fraser ID, Mitchell R, Murphy MF, Napier JA, Phillips P, Rejman AJ, Waters AH, Wood JK: Guidelines for the administration of blood products: Transfusion of infants and neonates, British Committee for Standards in Hematology Blood Transfusion Task Force. Transfus Med 1994; 4:63-9
14. Linden JV, Paul B, Dressler KP: A report of 104 transfusion errors in New York State. Transfusion 1992; 32:601-6
15. Linden JV, Kaplan HS: Transfusion errors: Causes and effects. Transfus Med Rev 1994; 8:169-83
16. Sazama K: Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 1990; 30:583-90
17. Alter MJ: Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C. Arch Pathol Lab Med 1994; 118:342-5
18. Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, Nelson KE: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327:369-73
19. Alter HJ: To C or not to C: These are the questions. Blood 1995; 85:1681-95
20. Centers for Disease Control and Prevention: Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991; 40(RR-4):1-17
21. Cumming PD, Wallace EL, Schorr JB, Dodd RY: Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative. N Engl J Med 1989; 32:941-6
22. Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, Sninsky J, Perkins HA, Vyas GN: Evaluation of screened blood donations for human immunodeficiency virus type I infection by culture and DNA amplification of pooled cells. N Engl J Med 1991; 325:1-5
23. Petersen LR, Satten GA, Dodd R, Busch M, Kleinman S, Grindon A, Lenes B, HIV Seroconversion Study Group: Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. Transfusion 1994; 34:283-9
24. Busch MP, Lee LLL, Satten GA, Henrard DR, Farzadegan HH, Nelson KE, Read S, Dodd RY, Petersen LR: Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors. Transfusion 1995; 35:91-7
25. Lacritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP, Petersen LR: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333:1721-5
26. Selik RM, Ward JW, Buehler JW: Demographic differences in cumulative incidence rates of transfusion-associated acquired immunodeficiency syndrome. Am J Epidemiol 1994; 140:105-12
27. Dodd RY: The risk of transfusion-transmitted infection. N Engl J Med 1992; 327:419-20
28. Blumberg N, Chuang-Stein C, Heal JM: The relationship of blood transfusion, tumor staging, and cancer recurrence. Transfusion 1990; 30:291-4
29. Vamvakas E, Moore SB: Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis. Transfusion 1993; 33:754-65
30. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J: Blood transfusion and prognosis in colorectal cancer. N Engl J Med 1993; 328:1372-6
31. Triulzi DJ, Vanek K, Ryan DH, Blumberg N: A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992; 32:517-24
32. Mezrow CK, Bergstein I, Tartter PI: Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992; 32:27-30
33. Murphy P, Heal JM, Blumberg N: Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991; 31:212-7
34. Edna TH, Bjerkeset T: Association between blood transfusion and infection in injured patients. J Trauma 1992; 33:659-61
35. Vamvakas EC, Moore SB: Blood transfusion and postoperative septic complications. Transfusion 1994; 34:714-27
36. Vamvakas EC, Moore SB, Cabanela M: Blood transfusion and septic complications after hip replacement surgery. Transfusion 1995; 35:150-6
37. Lubarsky DA, Hahn C, Bennett DH, Smith LR, Bredehoeft SJ, Klein HG, Reves JG: The hospital cost (fiscal year 1991/1992) of a simple perioperative allogeneic red blood cell transfusion during elective surgery at Duke University. Anesth Analg 1994; 79:629-37
38. Forbes JM, Anderson MD, Anderson GF, Bleecker GC, Rossi EC, Moss GS: Blood transfusion costs: A multicenter study. Transfusion 1991; 31:318-23
39. Goodnough LT, Soegiarso RW, Birkmeyer JD, Welch HG: Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med 1993; 94:509-14
40. Lawrence VA, Birch S, Gafni A: The impact of new clinical guidelines on the North American blood economy. Transfus Med Rev 1994; 8:232-41
41. Rosen NR, Bates LH, Herod G: Transfusion therapy: Improved patient care and resource utilization. Transfusion 1993; 33:341-7
42. Clarke AM, Dorman T, Bell MJ: Blood loss and transfusion requirements in total joint arthroplasty. Ann R Coll Surg Engl 1992; 74:360-3
43. Goodnough LT, Verbrugge D, Vizmeg K, Riddell J IV: Identifying elective orthopedic surgical patients transfused with amounts of blood in excess of need: The transfusion trigger revisited <ob>published erratum appears in Transfusion 1992; 32:838<cb> Transfusion 1992; 32:648-53
44. Gianoutsos MP, Thompson JF, Storey DW, Kronenberg H: The rational use of homologous blood in elective surgery. Aust N Z J Surg 1992; 62:266-9
45. Hallissey MT, Crowson MC, Kiff RS, Kingston RD, Fielding JW: Blood transfusion: An overused resource in colorectal cancer surgery. Ann R Coll Surg Engl 1992; 74:59-62
46. Thompson A, Contreras M, Knowles S: Blood component treatment: A retrospective audit in five major hospitals. J Clin Pathol 1991; 44:734-7
47. Morrison JC, Sumrall DD, Chevalier SP, Robinson SV, Morrison FS, Wiser WL: The effect of provider education on blood utilization practices. Am J Obstet Gynecol 1993; 169:1240-5
48. Brandis K, Richards B, Ghent A, Weinstein S: A strategy to reduce inappropriate red blood cell transfusion. Med J Aust 1994; 160:721-2
49. Hasley PB, Lave JR, Kapoor WN: The necessary and the unnecessary transfusion: A critical review of reported appropriateness rates and criteria for red cell transfusions. Transfusion 1994; 34:110-5
50. Ghali WA, Palepu A, Paterson WG: Evaluation of red blood cell transfusion practices with the use of preset criteria. Can Med Assoc J 1994; 150:1449-54
51. American College of Surgeons, Committee on Trauma: Advanced Trauma Life Support Course Manual. Chicago, American College of Surgeons, 1989
52. Messmer K, Sunder-Plassmann L, Jesch F, G<auo>rnandt L, Sinagowitz E, Kessler M: Oxygen supply to the tissues during limited normovolemic hemodilution. Res Exp Med 1973; 159:152-66
53. Czer LSC, Shoemaker WC: Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet 1978; 147:363-8
54. Delano BG, Nacht R, Friedman EA, Krasnow N: Myocardial anerobiosis in anemia in man. Circulation 1970; 42(suppl 3):148
55. Jan KM, Heldman J, Chien S: Coronary hemodynamics and oxygen utilization after hematocrit variations in hemorrhage. Am J Physiol 1980; 239:H326-32
56. Doak GJ, Hall RI: Does hemoglobin concentration affect perioperative myocardial lactate flux in patients undergoing coronary artery bypass surgery? Anesth Analg 1995; 80:910-16
57. Johansen SH, Laver MB: Cardiovascular effects of severe anemic hypoxia. Acta Anaesth Scand 1966; 24(suppl):63-8
58. Varat MA, Adolph RJ, Fowler NO: Cardiovascular effects of anemia. Am Heart J 1972; 83:415-26
59. Hemminki E, Starfield B: Prevention of low birth weight and pre-term birth: Literature review and suggestions. Milbank Mem Fund Q Health Soc 1978; 56:339-61
60. Murphy JF, O'Riordan J, Newcombe RG, Coles EC, Pearson JF: Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1986; 1:992-4
61. Paulone ME, Edelstone DI, Shedd A: Effects of maternal anemia on uteroplacental and fetal oxidative metabolism in sheep. Am J Obstet Gynecol 1987; 156:230-7
62. Delpapa EH, Edelstone DI, Milley JR, Balsan M: Effects of chronic maternal anemia on systemic and uteroplacental oxygenation in near-term pregnant sheep. Am J Obstet Gynecol 1992; 166:1007-12
63. Spahn DR, Leone BJ, Reves JG, Pasch T: Cardiovascular and coronary physiology of acute isovolemic hemodilution: A review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 1994; 78:1000-21
64. Viele MK, Weiskopf RB: What can we learn about the need for transfusion from patients who refuse blood?: The experience with Jehovah's Witnesses. Transfusion 1994; 34:396-401
65. Carson JL, Spence RK, Poses RM, Bonavita G: Severity of anaemia and operative mortality and morbidity. Lancet 1988; 1:727-9
66. Spence RK, Carson JA, Poses R, McCoy S, Pello M, Alexander J, Popovich J, Norcross E, Camishion RC: Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990; 159:320-4
67. Spence RK, Alexander JB, DelRossi AJ, Cernaianu AD, Cilley J Jr, Pello MJ, Atabek U, Camishion RC, Vertrees RA: Transfusion guidelines for cardiovascular surgery: Lessons learned from operations in Jehovah's Witnesses. J Vasc Surg 1992; 16:825-31
68. Kitchens CS: Are transfusions overrated?: Surgical outcome of Jehovah's Witnesses. Am J Med 1993; 94:117-9
69. Spence RK, Costabile JP, Young GS, Norcross ED, Alexander JB, Pello MJ, Atabek UM, Camishion RC: Is hemoglobin level alone a reliable predictor of outcome in the severely anemic surgical patient? Am Surg 1992; 58:92-5
70. Stehling L, Simon TL: The red blood cell transfusion trigger: Physiology and clinical studies. Arch Pathol Lab Med 1994; 118:429-34
71. Gould SA, Sehgal LR, Sehgal HL, Moss GS: Hypovolemic shock. Crit Care Clin 1993; 9:239-59
72. Levy PS, Chavez RP, Crystal GJ, Kim SJ, Eckel PK, Sehgal LR, Sehgal HL, Salem MR, Gould SA: Oxygen extraction ratio: A valid indicator of transfusion need in limited coronary vascular reserve? J Trauma 1992; 32:769-73
73. van Woerkens ECSM, Trouwborst A, van Lanschot JJB: Profound hemodilution: What is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg 1992; 75:818-21
74. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990; 323:1781-8
75. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, Krupski WC: Perioperative myocardial ischemia in patients undergoing noncardiac surgery: I. Incidence and severity during the 4 day perioperative period. J Am Coll Cardiol 1991; 17:843-50
76. Jonsson K, Jensen JA, Goodson WH III, Scheuenstuhl H, West J, Hopf HW, Hunt TK: Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Ann Surg 1991; 214:605-13
77. Wiesen AR, Hospenthal DR, Byrd JC, Glass KL, Howard RS, Diehl LF: Equilibration of hemoglobin concentration after transfusion in medical inpatients not actively bleeding. Ann Intern Med 1994; 121:278-80
78. Cooley DA, Bloodwell RD, Beall AC Jr, Hallman GL: Cardiac valve replacement without blood transfusion. Am J Surg 1966; 112:743-51
79. Finlayson DC, Suri RK: Management of open heart surgery without the use of blood: The function of blood volume determinations. Can Anaesth Soc J 1972; 19:335-8
80. Aris A, Padro JM, Bonnin JO, Caralps JM: Prediction of hematocrit changes in open-heart surgery without blood transfusion. J Cardiovasc Surg (Torino) 1984; 25:545-8
81. Makuuchi M, Takayama T, Gunven P, Kosuge T, Yamazaki S, Hasegawa H: Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989; 13:644-8
82. Jamieson GG, Corbel L, Campion JP, Launois B: Major liver resection without a blood transfusion: Is it a realistic objective? Surgery 1992; 112:32-6
83. Wittmann PH, Wittmann FW: Total hip replacement surgery without blood transfusion in Jehovah's Witnesses. Br J Anaesth 1992; 68:306-7
84. Kim DM, Brecher ME, Estes TJ, Morrey BF: Relationship of hemoglobin level and duration of hospitalization after total hip arthroplasty: Implications for the transfusion target. Mayo Clin Proc 1993; 68:37-41
85. Benjamin I, Barakat RR, Curtin JP, Jones WB, Lewis JL Jr, Hoskins WJ: Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infection. Obstet Gynecol 1994; 84:974-8
86. Mann R, Heimbach DM, Engrav LH, Foy H: Changes in transfusion practices in burn patients. J Trauma 1994; 37:220-2
87. Sittig KM, Deitch EA: Blood transfusions: For the thermally injured or for the doctor? J Trauma 1994; 36:369-72
88. Nelson AH, Fleisher LA, Rosenbaum SH: Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993; 21:860-6
89. Babineau TJ, Dzik WH, Borlase BC, Baxter JK, Bistrian BR: Reevaluation of current transfusion practices in patients in surgical intensive care units. Am J Surg 1992; 164:22-5
90. Dietrich KA, Conrad SA, Hebert CA, Levy GL, Romero MD: Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med 1990; 18:940-4
91. Lorente JA, Landin L, De Pablo R, Renes E, Rodriguez-Diaz R, Liste D: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1993; 21:1312-8
92. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269:3024- 9
93. Hebert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, Blajchman M: Transfusion requirements in critical care: A pilot study. JAMA 1995; 273:1439-44
94. Royal College of Physicians of Edinburgh: Consensus statement on red cell transfusion. Transfus Med 1994; 4:177-8
95. Faust RJ: Perioperative indications for red blood cell transfusion: Has the pendulum swung too far? Mayo Clin Proc 1993; 68:512-4
96. Gmur J, Burger J, Schanz U, Fehr J, Schaffner A: Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338:1223-6
97. Bishop JF, Schiffer CA, Aisner J, Matthews JP, Wiernik PH: Surgery in acute leukemia: A review of 167 operations in thrombocytopenic patients. Am J Hematol 1987; 26:147-55
98. McVay PA, Toy PTCY: Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion 1991; 31:164-71
99. Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ: Hemostasis in massively transfused trauma patients. Ann Surg 1979; 190:91-9
100. Miller RD: Complications of massive blood transfusions. ANESTHESIOLOGY 1973; 39:82-93
101. Reed RL, Heimbach DM, Counts RB, Ciavarella D, Baron L, Carrico CJ, Pavlin E: Prophylactic platelet administration during massive transfusion. Ann Surg 1986; 203:40-8
102. Ciaverella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ: Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67:365-8
103. Leslie SD, Toy PTCY: Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 1991; 96:770-3
104. Anteby E, Shalev O: Clinical relevance of gestational thrombocytopenia of <100,000/ul. Am J Hematol 1994; 47:118-22
105. Rasmus KT, Rottman RL, Kotelko DM, Wright WC, Stone JJ, Rosenblatt RM: Unrecognized thrombocytopenia and regional anesthesia in parturients: A retrospective review. Obstet Gynecol 1989; 73:943-6
106. Laros RK Jr, Kagan R: Route of delivery for patients with immune thrombocytopenic purpura. Am J Obstet Gynecol 1984; 148:901-8
107. Katz VL, Thorp JM Jr, Rozas L, Bowes WA Jr: The natural history of thrombocytopenia associated with preeclampsia. Am J Obstet Gynecol 1990; 163:1142-3
108. Martin JN, Blake PG, Perry KG, McCaul JF, Hess LW, Martin RW: The natural history of HELLP syndrome: Patterns of disease progression and regression. Am J Obstet Gynecol 1991; 164:1500-13
109. Neiger R, Contag SA, Coustan DR: The resolution of preeclampsia-related thrombocytopenia. Obstet Gynecol 1991; 77:692-5
110. Ray MJ, Hawson GAT, Just SJE, McLachlan G, O'Brien M: Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994; 57:981-6
111. Burns ER, Lawrence C: Bleeding time: A guide to its diagnostic and clinical utility. Arch Pathol Lab Med 1989; 113:1219-24
112. Rodgers RP, Levin J: A critical appraisal of the bleeding time. Semin Thromb Hemost 1990; 16:1-20
113. Lind SE: The bleeding time does not predict surgical bleeding. Blood 1991; 77:2547-52
114. British Committee for Standards in Haematology: Guidelines for platelet transfusions. Transfus Med 1992; 2:311-8
115. Higby DJ, Cohen E, Holland JF, Sinks L: The prophylactic treatment of thrombocytopenic leukemic patients with platelets: A double blind study. Transfusion 1974; 14:440-6
116. Murphy S, Litwin S, Herring LM, Koch P, Remischovsky J, Donaldson MH, Evans AE, Gardner FH: Indications for platelet transfusion in children with acute leukemia. Am J Hematol 1982; 12:347-56
117. Simon TL, Abel BF, Murphy W: Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg 1984; 37:359-64
118. Pisciotto PT, Benson K, Hume H, Glassman AB, Oberman H, Popovsky M, Hines D, Anderson K: Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995; 35:498-502
119. Blumberg N, Laczin J, McMican A, Heal J, Arvan D: A critical survey of fresh-frozen plasma use. Transfusion 1986; 26:511-3
120. Shanberge JN, Quattrociocchi-Longe T: Analysis of fresh frozen plasma administration with suggestions for ways to reduce usage. Transfus Med 1992; 2:189-94
121. Murray DJ, Olson J, Strauss R, Tinker JH: Coagulation changes during packed red cell replacement of major blood loss. ANESTHESIOLOGY 1988; 69:839-45
122. Flaum MA, Cuneo RA, Applebaum FR, Deisseroth AB, Ensel WK, Gralnick HR: The hemostatic imbalance of plasma-exchange transfusion. Blood 1979; 54:694-702
123. Domen RE, Kennedy MS, Jones LL, Senhauser DA: Hemostatic imbalances produced by plasma exchange. Transfusion 1984; 24:336-9
124. Miller RD, Robbins TO, Tong MJ, Barton SL: Coagulation defects associated with massive blood transfusions. Ann Surg 1971; 174:794-801
125. Lucas CE, Ledgerwood AM: Clinical significance of altered coagulation tests after massive transfusion for trauma. Ann Surg 1981; 47:125-30
126. Mannucci PM, Federici AB, Sirchia G: Hemostasis testing during massive blood replacement: A study of 172 cases. Vox Sang 1982; 42:113-23
127. Murray DJ, Pennell BJ, Weinstein SL, Olson JD: Packed red cells in acute blood loss: Dilutional coagulopathy as a cause of surgical bleeding. Anesth Analg 1995; 80:336-42
128. Harke H, Rahman S: Haemostatic disorders in massive transfusion. Biblthca Haematol 1980; 46:179-88
129. Hewson JR, Neame PB, Kumar N, Ayrton A, Gregor, Davis C, Shragge BW: Coagulopathy related to dilution and hypotension during massive transfusion. Crit Care Med 1985; 13:387-91
130. Faringer PD, Mullins RJ, Johnson RL, Trunkey DD: Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 1993; 34:481-7
131. Eika C, Havie O, Godal HC: The value of preoperative haemostatic screening. Scand J Haematol 1978; 21:349-54
132. Robbins JA, Rose SD: Partial thromboplastin time as a screening test. Ann Intern Med 1979; 90:796
133. Friedman EW, Sussman II: Safety of invasive procedures in patients with the coagulopathy of liver disease. Clin Lab Haematol 1989; 11:199-204
134. Ewe K: Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981; 26:388-93
135. Foster PF, Moore LR, Sankary HN, Hart ME, Ashmann MK, Williams JW: Central venous catheterization in patients with coagulopathy. Arch Surg 1992; 127:273-5
136. Proietti AB, Johnson MJ, Proietti FA, Repke JT, Bell WR: Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-based agglutination. Obstet Gynecol 1991; 77:696-700
137. Spector I, Corn M, Ticktin HE: Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease. N Engl J Med 1966; 275:1032-7
138. Roy RC, Stafford MA, Hudspeth AS, Meredith JW: Failure of prophylaxis with fresh frozen plasma after cardiopulmonary bypass. ANESTHESIOLOGY 1988; 69:254-7
139. British Committee for Standards in Haematology: Guidelines for the use of fresh frozen plasma. Transfus Med 1992; 2:57-63
140. Gilabert J, Estelles A, Aznar J, Galbis M: Abruptio placentae and disseminated intravascular coagulation. Acta Obstet Gynecol Scand 1985; 64:35-9
141. Green D, Potter EV: Failure of AHV concentrate to control bleeding in von Willebrand's disease. Am J Med 1976; 60:357-60
142. Holmberg L, Nilsson IM: Von Willebrand's disease. Eur J Haematol 1992; 48:127-41
143. Aledort LM: Treatment of von Willebrand's disease. Mayo Clin Proc 1991; 66:841-6
144. Schulman S: DDAVP--the multipotent drug in patients with coagulopathies. Transfus Med Rev 1991; 5:132-44
145. Rodeghiero F, Castaman G, Meyer D, Mannucci PM: Replacement therapy with virus-inactivated plasma concentrates in von Willebrand disease. Vox Sang 1992; 62:193-9
146. Hoyer LW: Hemophilia A. N Engl J Med 1994; 330:38-47
147. Sutton DM, Hauser R, Kulapongs P, Bachmann F: Intravascular coagulation in abruptio placentae. Am J Obstet Gynecol 1971; 1,000,000,000:604-14
148. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, Fink A, Brook R: The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332:719-24
149. Lichtiger B, Fischer HE, Huh YO: Screening of transfusion service requests by the blood bank pathologist: Impact on cost containment. Lab Med 1988; 19:228-30
150. Blanchette VS, Hume HA, Levy GJ, Luban NL, Strauss RG: Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child 1991; 145:787-96
151. Toy PTCY: Effectiveness of transfusion audits and practice guidelines. Arch Pathol Lab Med 1994; 118:435-7
152. Despotis GJ, Grishaber JE, Goodnough LT: The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion 1994; 34:290-6
153. Paone G, Spencer T, Silverman NA: Blood conservation in coronary artery surgery. Surgery 1994; 116:672-8
154. Renner SW, Howanitz JH, Fishkin BG: Toward meaningful blood usage review: Comprehensive monitoring of physician practice. QRB 1987; 13:76-80
155. Lepage EF, Gardner RM, Laub RM, Golubjatnikov OK: Improving blood transfusion practice: Role of a computerized hospital information system. Transfusion 1992; 32:253-9
156. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA: A controlled trial of educational outreach to improve blood transfusion practice. JAMA 1993; 270:961-6
157. Shanberge JN: Reduction of fresh frozen plasma use through a daily survey and education program. Transfusion 1987; 27:226-7
158. Solomon RR, Clifford JS, Gutman SI: The use of laboratory intervention to stem the flow of fresh-frozen plasma. Am J Clin Pathol 1988; 89:518-21
159. Ayoub MM, Clark JA: Reduction of fresh frozen plasma use with a simple education program. Am Surg 1989; 55:563-5
160. Barnette RE, Fish DJ, Eisenstaedt RS: Modification of fresh-frozen plasma transfusion practices through educational intervention. Transfusion 1990; 30:253-7
161. Simpson MB: Prospective-concurrent audits and medical consultation for platelet transfusions. Transfusion 1987; 27:192-5
162. McCullough J, Steeper TA, Connelly DP, Jackson B, Huntington S, Scott EP: Platelet utilization in a university hospital. JAMA 1988; 259:2414-8